SCHEMBL626431

SCHEMBL626431

CCCCCCCCCCCCCC(C(=O)[O-])C(CCCCCCCCCCCCC)(C(=O)[O-])S(=O)(=O)O.[Na+].[Na+]

nearest known ligand 0.45

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 known ✓ P00918 2/20 0.45
CA1 known ✓ P00915 2/20 0.42
GPR84 Q9NQS5 6/20 0.39
NFKB1 P19838 2/20 0.36
TP53 P04637 1/20 0.36
HSPD1 P10809 1/20 0.35
BLM P54132 1/20 0.35
HSPE1 P61604 1/20 0.35
FFAR1 O14842 1/20 0.33
MEN1 O00255 1/20 0.33
HPGD P15428 1/20 0.33
RECQL P46063 1/20 0.33
KMT2A Q03164 1/20 0.33
HSD17B10 Q99714 1/20 0.33
MAPT P10636 1/20 0.33
LCK P06239 1/20 0.33
PPARD Q03181 1/20 0.33
ZDHHC20 Q5W0Z9 1/20 0.33
ZDHHC2 Q9UIJ5 1/20 0.33
CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL472821 1.00 CA2 (0.45) CA2CA1GPR84NFKB1TP53
SCHEMBL1283043 1.00 CA2 (0.45) CA2CA1GPR84NFKB1TP53
SCHEMBL7100617 1.00 CA2 (0.45) CA2CA1GPR84NFKB1TP53
SCHEMBL9651098 1.00 CA2 (0.45) CA2CA1GPR84NFKB1TP53
SCHEMBL7095269 1.00 CA2 (0.45) CA2CA1GPR84NFKB1TP53
SCHEMBL223462 1.00 CA2 (0.45) CA2CA1GPR84NFKB1TP53
SCHEMBL7100032 1.00 CA2 (0.45) CA2CA1GPR84NFKB1TP53
SCHEMBL7098224 1.00 CA2 (0.45) CA2CA1GPR84NFKB1TP53
SCHEMBL15520 1.00 CA2 (0.45) CA2CA1GPR84NFKB1TP53
SCHEMBL7207855 1.00 CA2 (0.45) CA2CA1GPR84NFKB1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 246 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4061857-B1 POLYMER DISPERSION MADE FROM (METH)ACRYLATES HAVING LONG SIDE CHAINS EVONIK OPERATIONS GMBH (DE) 2026-05-06 EP claimed
EP-4029885-B1 METHOD FOR PRODUCING VINYL CHLORIDE-BASED POLYMER LG CHEMICAL LTD (KR) 2024-12-18 EP claimed
US-20240299273-A1 MULTIPHASIC LIQUID COMPOSITIONS FOR IMPROVED DEPOSITION OF ACTIVE INGREDIENTS SPECIALITY OPERATIONS FRANCE (FR) 2024-09-12 US claimed
US-20240115476-A1 COMPOSITIONS COMPRISING A MULTI-TAIL SURFACTANT AND A CATIONIC POLYMER AND USES RHODA OPERATIONS (FR) 2024-04-11 US claimed
EP-4288027-A1 MULTIPHASIC LIQUID COMPOSITIONS FOR IMPROVED DEPOSITION OF ACTIVE INGREDIENTS SPECIALTY OPERATIONS FRANCE (FR) 2023-12-13 EP claimed
EP-4288026-A1 COMPOSITIONS COMPRISING A MULTI-TAIL SURFACTANT AND A CATIONIC POLYMER AND USES SPECIALTY OPERATIONS FRANCE (FR) 2023-12-13 EP claimed
CN-114773518-B Copolymer emulsion, aqueous base material of paint and preparation method thereof 河北四友卓越科技有限公司 2023-10-13 CN claimed
EP-2916820-B1 DELIVERY OF BIOLOGICALLY-ACTIVE AGENTS USING VOLATILE, HYDROPHOBIC SOLVENTS ROCHAL TECH LLC (US) 2023-10-11 EP claimed
WO-2022167673-A1 MULTIPHASIC LIQUID COMPOSITIONS FOR IMPROVED DEPOSITION OF ACTIVE INGREDIENTS RHODIA OPERATIONS (FR) 2022-08-11 WO claimed
WO-2022167672-A1 COMPOSITIONS COMPRISING A MULTI-TAIL SURFACTANT AND A CATIONIC POLYMER AND USES RHODIA OPERATIONS (FR) 2022-08-11 WO claimed
WO-2002033001-A1 SYNTHETIC LEATHER MANUFACTURING METHOD USING AQUEOUS POLYURETHANE DISPERSIONS NANOPOL INC. (KR) 2002-04-25 WO claimed
EP-0935019-A1 Coating agent for fibers Bayer Aktiengesellschaft (DE) 1999-08-11 EP claimed
EP-0635548-B1 Thermoplastic resin composition MITSUBISHI CHEM CORP (JP) 1998-03-11 EP claimed
EP-0186361-B2 Thickeners for thickening aqueous media SCOTT BADER CO (GB) 1994-04-27 EP claimed
EP-0186361-B1 THICKENERS FOR THICKENING AQUEOUS MEDIA SCOTT BADER COMPANY LIMITED (GB) 1990-09-12 EP claimed
EP-0107407-B1 EMULSION EXPLOSIVE COMPOSITION CIL INC (CA) 1988-12-21 EP claimed
EP-0106526-B1 HYDROCARBON SOLVENT-BASED DISPERSANT FORMULATION AND ITS USE IN THE DISPERSION OF VISCOUS OIL SPILLS EXXON RESEARCH AND ENGINEERING COMPANY (US) 1988-03-16 EP claimed
US-4539368-A Technology for the production of inverse emulsion polymers AZS CORPORATION (US) 1985-09-03 US claimed
US-4153549-A Sodium dialkyl sulfosuccinates as dewatering aids in the filtration of mineral concentrates AMERICAN CYANAMID COMPANY (US) 1979-05-08 US claimed
US-4022731-A ACRYLAMIDE, OIL, EMULSIFYING AGENT AMERICAN CYANAMID COMPANY (US) 1977-05-10 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240115476-A1 COMPOSITIONS COMPRISING A MULTI-TAIL SURFACTANT AND A CATIONIC POLYMER AND USES PHOSPHO1, SGMS1, SGMS2 CA2 2289/4885CA1 3841/4885GPR84 2275/4885
US-20240299273-A1 MULTIPHASIC LIQUID COMPOSITIONS FOR IMPROVED DEPOSITION OF ACTIVE INGREDIENTS MATR3, ELANE, CUTA CA2 3457/4885CA1 3626/4885GPR84 3584/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.